ArticleProceedings of the National Academy of Sciences of the United States of America2021

Cancer-associated mutations in the p85α N-terminal SH2 domain activate a spectrum of receptor tyrosine kinases.

Xinran Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.